Golimumab (Anti-TNFSF2 / TNFa)
Golimumab (Anti-TNFSF2 / TNFa) (A2892-GRP)
Products
Description
Golimumab (Anti-TNFSF2 / TNFa) is a human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. MW: 146.94 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2892 |
| Target | TNF-alpha |